The Kenya Medical Research Institute (KEMRI) is banking on its locally produced products, including disinfectants, repellents, Personal Protective Equipment (PPEs) and diagnostic kits, to generate revenue and sustain critical research programmes.
This follows the decision by United States of America (US) President Donald Trump to cut foreign aid, a move that has significantly impacted the organisation's operations.
KEMRI Director General (DG), Prof.
Elijah Songok, revealed that the funding cuts have affected 40 % of the institute's programmes, putting approximately 824 staff members at risk of losing their jobs.
